Results 181 to 190 of about 429,323 (284)
A real-world pharmacovigilance study of Certolizumab pegol based on FAERS database. [PDF]
Liu M, Yin P, Fan R, Zhang G, Zhao K.
europepmc +1 more source
This study determines the maximum tolerated dose of lenvatinib in combination with paclitaxel as second‐line therapy for advanced gastric cancer patients. A dynamic network biomarker panel associated with patient prognosis and response to treatment is established.
Chenfei Zhou+8 more
wiley +1 more source
Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results. [PDF]
Shadman M+13 more
europepmc +1 more source
This review comprehensively examines the applications of protein three‐dimensional structures and artificial intelligence in investigating drug synergistic and antagonistic effects. The research findings provide compelling evidence for the precision treatment of cancer and metabolic diseases, thereby promoting the development of personalized medicine ...
Anqi Lin+11 more
wiley +1 more source
Safety assessment of Osilodrostat: The adverse event analysis based on FAERS database by means of disproportionality analysis. [PDF]
Li L, Zhao W.
europepmc +1 more source
Tune metal‐support interaction to induce formation of crystalline/amorphous Ru interface towards zero‐drag hydrogen generation from hybrid alkaline seawater electrolysis. Abstract Hydrazine‐assisted hybrid alkaline seawater electrolysis offers a dual‐functional platform for environmentally benign remediation of toxic hydrazine and energy‐autonomous ...
Dongquan Yang+6 more
wiley +1 more source
The contribution of surgical data science to identifying intraoperative human errors and adverse events in elective liver surgery: A preliminary study. [PDF]
Mekhenane N+6 more
europepmc +1 more source